Mastopexy With Autologous Augmentation in Women After Massive Weight Loss - A Clinical, Randomized Study

NCT02572271 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2018-08-22

No results posted yet for this study

Summary

The purpose of this study is to compare two different techniques of mastopexy with autologous augmentation, the Lower Pole Subglandular Advancement Mastoplasty (LOPOSAM) and Rubins Mastopexy with autologous augmentation, in massive weight loss patients to see if one technique is superior to the other.

Conditions

Interventions

PROCEDURE

Rubins Mastopexy

The surgical technique described by Rubin is performed. No other intervention.

PROCEDURE

LOPOSAM

The surgical technique LOPOSAM is performed. No other intervention.

Sponsors & Collaborators

  • Odense University Hospital

    lead OTHER

Principal Investigators

  • Peder Ikander, MD · Department of Plastic and Reconstructive Surgery, Odense University Hospital, Odense, Denmark

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-09-30
Primary Completion
2017-11-16
Completion
2017-11-16

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02572271 on ClinicalTrials.gov